PIK3CA mutations are associated with reduced pathological complete response rates in primary HER2-positive breast cancer: pooled analysis of 967 patients from five prospective trials investigating lapatinib and trastuzumab. (26th April 2018)

Record Type:: Journal Article
Title:: PIK3CA mutations are associated with reduced pathological complete response rates in primary HER2-positive breast cancer: pooled analysis of 967 patients from five prospective trials investigating lapatinib and trastuzumab. (26th April 2018)
Main Title:: PIK3CA mutations are associated with reduced pathological complete response rates in primary HER2-positive breast cancer: pooled analysis of 967 patients from five prospective trials investigating lapatinib and trastuzumab
Authors:: Loibl, S
Majewski, I
Guarneri, V
Nekljudova, V
Holmes, E
Bria, E
Denkert, C
Schem, C
Sotiriou, C
Loi, S
Untch, M
Conte, P
Bernards, R
Piccart, M
von Minckwitz, G
Baselga, J
Abstract:
Is Part Of:: Annals of oncology. Volume 29:Number 10(2018)
Journal:: Annals of oncology
Issue:: Volume 29:Number 10(2018)
Issue Display:: Volume 29, Issue 10 (2018)
Year:: 2018
Volume:: 29
Issue:: 10
Issue Sort Value:: 2018-0029-0010-0000
Page Start:: 2151
Page End:: 2151
Publication Date:: 2018-04-26
Subjects:: Oncology -- Periodicals
616.992
Journal URLs:: https://www.journals.elsevier.com/annals-of-oncology ↗
http://ukcatalogue.oup.com/ ↗
DOI:: 10.1093/annonc/mdx803 ↗
Languages:: English
ISSNs:: 0923-7534
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 1043.320000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 16506.xml